...
首页> 外文期刊>Reviews on environmental health >Linking childhood allergic asthma phenotypes with endotype through integrated systems biology: current evidence and research needs
【24h】

Linking childhood allergic asthma phenotypes with endotype through integrated systems biology: current evidence and research needs

机译:通过综合系统生物学将儿童过敏性哮喘表型与内型联系起来:当前证据和研究需求

获取原文
获取原文并翻译 | 示例
           

摘要

Asthma and other complex diseases results from a complex web of interactions involving inflammation, immunity, cell cycle, apoptosis, and metabolic perturbations across multiple organ systems. The extent to which various degrees of the age at onset, symptom severity, and the natural progression of the disease reflect multiple disease subtypes, influenced by unique process of development remains unknown. One of the most critical challenges to our understanding stems from incomplete understanding of the mechanisms. Within this review, we focus on the phenotypes of childhood allergic asthma as the basis to better understand the endotype for quantitative define subtypes of asthma. We highlight some of the known mechanistic pathways associated with the key hallmark events before the asthma onset. In particular, we examine how the recent advent of multiaxial -omics technologies and systems biology could help to clarify our current understanding of the pathway. We review how a large volume of molecular, genomic data generated by multiaxial technologies could be digested to identify cogent pathophysiologic molecular networks. We highlight some recent successes in application of these technologies within the context of other disease conditions for therapeutic interventions. We conclude by summarizing the research needs for the predictive value of preclinical biomarkers.
机译:哮喘和其他复杂疾病是由相互作用的复杂网络导致的,涉及炎症,免疫力,细胞周期,细胞凋亡以及跨多个器官系统的代谢紊乱。发病的不同程度,症状严重程度和疾病的自然进展反映出多种疾病亚型的程度在多大程度上受到独特发展过程的影响仍然未知。对我们理解的最关键挑战之一是对机制的不完全理解。在这篇综述中,我们将重点放在儿童过敏性哮喘的表型上,以此作为更好地了解内在型以定量定义哮喘亚型的基础。我们着重介绍了与哮喘发作前的关键标志事件相关的一些已知机制途径。特别是,我们研究了最近出现的多轴组学技术和系统生物学如何帮助阐明我们目前对该途径的理解。我们审查了如何消化由多轴技术产生的大量分子,基因组数据,以鉴定有力的病理生理分子网络。我们重点介绍了在其他疾病条件下用于治疗干预的这些技术的最新应用成果。通过总结对临床前生物标记物的预测价值的研究需求来得出结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号